The Ergomed team look forward to exhibiting at the World Orphan Drug Congress USA taking place in Boston, MA, between 11-13 July.
The World Orphan Drug Congress USA brings together leading pharmaceutical and biotech companies, government and regulatory authorities, patient advocacy groups, payers, investors, and solution providers. The conference is a place to meet and brainstorm ways to advance orphan drug development and improve access to life-saving therapies.
Our Ergomed Rare Disease team will be exhibiting for three days in Boston for the most comprehensive program and inclusive gathering of rare disease stakeholders.
If attending, we encourage you to listen to Ergomed rare disease expert, Zizi Imatorbhebhe, on Leveraging technology platforms: Evolving the IND/regulatory process and funding models to meet the needs of more patients invited as a panel speaker.
We invite you to visit our booth, #528, to meet our expert, together with our commercial team and have a chance to win our raffle.
Zizi Imatorbhebhe, MBA, MS, PMP®
Senior Vice President, Global Strategy and Development,
Head Rare Disease Innovation Center
Danko Dominis, MD, PhD
SVP Business Development & Strategic Accounts
danko.dominis@ergomedplc.com
Jane McNiff
Senior Director, Business Development
jane.mcniff@ergomedplc.com
Bojana Mirosavljevic
Patient Engagement Officer
bojana.mirosavljevic@ergomedplc.com
For more information about this event, please visit https://www.terrapinn.com/conference/world-orphan-drug-congress-usa/index.stm.
If you have any questions or want to set up a meeting with the Ergomed team during the World Orphan Drug Congress USA, you can email us at marketing@ergomedplc.com.
